Startups attracted $91.5 billion in venture capital funding in Q1, according to the latest report from data provider PitchBook. This figure not only exceeds the previous quarter's allocation by 18.5% ...

President Donald Trump’s tariffs are drawing swift retaliation from China, Canada and the European Union, deepening the ...

Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...

Nineteen-year Google veteran Sissie Hsiao, who led its consumer AI apps such as its chatbot Gemini, has stepped down and will ...

Plus, a veteran VC is moving to the other side of the table. Thriving: AI drug-discovery platform Isomorphic Labs raised a $600 million round, its first external funding since spinning out of Google’s ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weekly Chicago Catch-Up newsletter. Some household names will feel the pinch from Vietnam tariffs.

Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector.

OpenAI’s latest image update to ChatGPT isn’t just a boon for Studio Ghibli fans. It’s also a gift to businesses of all sizes ...

Iso­mor­phic Labs wants to achieve “max­i­mum ac­cel­er­a­tion” on its drug dis­cov­ery re­search progress, Demis Has­s­abis told End­points News.

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, Isomorphic Labs.